Antibiotic Manufacturer

Conduct Research

• Dust-tight Powder Conveying, with a Twist
  , including a new antibiotic paste that is squirted by syringe into the mouths of horses. Previously, Macleod had outsourced all of its manufacturing needs. But it had difficulty finding a contract manufacturer for a specialized paste. Larger manufacturers said, We ll do it. How many million do you...
• Air Motors for use in the Medical Industry
  In Europe at least 50,000 patients a year die from infections which they acquire in hospital. Due to this alarming number, at the beginning of 2008 the German Association for Hospital Hygiene (DGKH) highlighted the dangers of this increasingly sore subject: Antibiotic resistant bacteria...
• Drug Delivery: The "Great Equalizer"
  mechanisms (diffusion, erosion, bi-layer and combinations of these) while sparing the stomach and large intestine, where many side effects originate. The company s Proquin XR (ciprofloxacin) antibiotic is said to provide steadier pharmacokinetics and fewer gastrointestinal side effects than conventional...
• Maintenance Management Joins the Party
  for Aventis Pharma (now part of the Sanofi-Aventis Group), which operates several product sites throughout France. The company elected to go with MRO Software s Maximo system to manage maintenance activities at its Compiegne, France facility, which manufactures a variety of antibiotic...
• Beating Patent Death
  Myers Squibb has licensed GR for metformin, a drug for type 2 diabetes. Depomed has also been working on GR-delivered ciprofloxacin (an antibiotic), furosemide (for heart failure), and gabapentin (a pain reliever). With so many delivery technologies available for line extensions, and with drug...
• Quality Systems Dominate at Interphex Dalian
  Pharmaceutical Company (CSPC) which is the second largest antibiotic and vitamin manufacturer and distributor in China, exporting $3 billion annually, is aware of the government’s concern regarding China’s lack of R&D facilities.“Only about 2% of our business is R&D currently. We know this is a problem...
• Will Pharma Wear the Energy Star?
  plants the same, and we’re not sure if that will be effective or not.” The model will seek to normalize facilities by dividing them into three categories: bulk chemical synthesis, antibiotic production/fermentation, and fill and finish. Tunnessen admits that more levels of normalization may...
• Can 13 Years of FDA Data Teach Us Anything?
  facilities are less likely to be found noncompliant. Facilities manufacturing antibiotics have a 19% greater chance of being inspected than those making other drugs, while those making vitamins have an 11% greater chance. Antibiotic plants also have a much greater likelihood of being out of compliance...
• Coping with Phase III Testing
  Monitor) RFID smart-sensor labels for an 1,100-patient Phase III study of a macrolide antibiotic used in subjects with emphysema. Enrollment is taking place at 17 study sites managed by 10 universities throughout the United States. Disposable Med-ic chips are part of a “smart” pharmaceutical...
• Therapeutic Dose: Playing the Villain
  the bacterial meningitis drug Trovan on their children without their knowledge. Some of the children died, and the suit questioned whether Pfizer, in testing Trovan, neglected to offer the children a more proven antibiotic. The court eventually ruled that the case could not be tried in the U.S.Clinical trials...

Engineering Web Search: Antibiotic Manufacturer